<DOC>
	<DOCNO>NCT00590213</DOCNO>
	<brief_summary>The primary objective trial examine value prophylactic versus therapeutic breast radiotherapy Casodex monotherapy induce gynaecomastia and/or breast pain . Patients receive either prophylactic radiotherapy breast dose 12Gy ( two fraction 6 Gy consecutives day ) , receive radiotherapy prior commence CASODEX 150mg monotherapy .</brief_summary>
	<brief_title>Compare Value Prophylactic Versus Therapeutic Breast Radiotherapy CASODEX</brief_title>
	<detailed_description />
	<mesh_term>Prostatic Neoplasms</mesh_term>
	<mesh_term>Bicalutamide</mesh_term>
	<criteria>Males patient age 18 year entry trial Patients nonmetastatic cancer confirm histology cytology . This primary treatment complete last 8 week The stage T1b/T1c/T2/T3/T4 N category Paitents must give write , fully inform consent participate trial prior trial specific assessment make Be able prepared comply trial procedure restriction Have life expectancy great 2 year Any known sensitivity radiation therapy condition investigator 's opinion may lead radiation sensitivity Patients concurrent malignancy ( except basal cell TO2 NO MO squamous cell carcinoma skin ) . History previous malignancy treatment cancer past 5 year Previous history mastectomy include Webster operation radiation therapy chest area Any previous treatment surgical medical castration , antiandrogens , monotherapy oestrogen therapy time Any evidence preexist gynaecomastia breast pain Patients history presence testicular abnormality ( CASODEX potentially aggravate testicular tumour ) Patients concurrent disease condition opinion treat physician , would constitute hazard participation study may interfere patient 's ability comply schedule visit assessment . This include patient whose physical build would prevent reasonable assessment gynaecomastia Liver disease ( bilirubin great 2.0mg/dL ; AST/ALT great 2 time upper limit normal ) Patients take follow drug ; terfenadine , cisapride , astemizole , cyclosporin , warfarin exclude trial due possibility drug interaction Patients known history alcohol abuse Concurrent treatment druges know high potential causing gynaecomastia breast pain , eg.Spironolactone , steroid therapy , cimetidine neuroleptic agent . Treatment new chemical entity within previous 4 month current participation another clinical trial involve investigational product Patients consider investigator risk transmit infection body body fluid , include acquire immue dificiency syndrome ( AIDS ) sexually transmit disease hepatitis</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>January 2008</verification_date>
	<keyword>Casodex</keyword>
	<keyword>Prostate Cancer</keyword>
</DOC>